Hormone Receptor-Positive / HER2-Negative Early Breast Cancer High-Risk Population: An Algorithm for Optimization Systemic Adjuvant Treatment Based on 2022 Updates

por González-Hurtado, Daniel, Rivero, Sergio, Samamé Pérez-Vargas, Juan Carlos, Petracci, Fernando E.
Publicado 2023